19543511000001102: Olanzapine 5mg tablets (Aspire Pharma Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Olanzapine 5mg tablets (Aspire Pharma Ltd)
\UK product\Virtual medicinal product\Product containing precisely olanzapine 5 milligram/1 each conventional release oral tablet\Olanzapine 5mg tablets (Aspire Pharma Ltd)
\UK product\Virtual therapeutic moiety\Olanzapine\Product containing only olanzapine in oral dose form (medicinal product form)\Product containing precisely olanzapine 5 milligram/1 each conventional release oral tablet\Olanzapine 5mg tablets (Aspire Pharma Ltd)
\UK product\Virtual therapeutic moiety\Olanzapine\Product containing precisely olanzapine 5 milligram/1 each conventional release oral tablet\Olanzapine 5mg tablets (Aspire Pharma Ltd)

\Medicinal product\Medicinal product categorized by structure\Product containing olanzapine\Olanzapine\Product containing only olanzapine in oral dose form (medicinal product form)\Product containing precisely olanzapine 5 milligram/1 each conventional release oral tablet\Olanzapine 5mg tablets (Aspire Pharma Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing olanzapine\Olanzapine\Product containing precisely olanzapine 5 milligram/1 each conventional release oral tablet\Olanzapine 5mg tablets (Aspire Pharma Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing olanzapine\Product containing olanzapine in oral dose form (medicinal product form)\Product containing only olanzapine in oral dose form (medicinal product form)\Product containing precisely olanzapine 5 milligram/1 each conventional release oral tablet\Olanzapine 5mg tablets (Aspire Pharma Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing olanzapine in oral dose form (medicinal product form)\Product containing only olanzapine in oral dose form (medicinal product form)\Product containing precisely olanzapine 5 milligram/1 each conventional release oral tablet\Olanzapine 5mg tablets (Aspire Pharma Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Oct 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

66172701000001111 Olanzapine 5mg tablets (Aspire Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

66172801000001119 Olanzapine 5mg tablets (Aspire Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Olanzapine 5mg tablets (Aspire Pharma Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Olanzapine 5mg tablets (Aspire Pharma Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Olanzapine 5mg tablets (Aspire Pharma Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Olanzapine 5mg tablets (Aspire Pharma Ltd)	Is a	Product containing precisely olanzapine 5 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Olanzapine 5mg tablets (Aspire Pharma Ltd)	Has active ingredient	Olanzapine	false	Inferred relationship	Existential restriction modifier
Olanzapine 5mg tablets (Aspire Pharma Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Olanzapine 5mg tablets (Aspire Pharma Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Olanzapine 5mg tablets (Aspire Pharma Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Olanzapine 5mg tablets (Aspire Pharma Ltd)	Has specific active ingredient	Olanzapine	true	Inferred relationship	Existential restriction modifier
Olanzapine 5mg tablets (Aspire Pharma Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Olanzapine 5mg tablets (Aspire Pharma Ltd)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
Olanzapine 5mg tablets (Aspire Pharma Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Olanzapine 5mg tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets	Has AMP	True	Olanzapine 5mg tablets (Aspire Pharma Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
66172701000001111	Olanzapine 5mg tablets (Aspire Pharma Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
66172801000001119	Olanzapine 5mg tablets (Aspire Pharma Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module